Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

Table 1 Interventions within Network Diagram

NO	Drug	Abbreviation	Patients
1	I.V Hydration	I.V	5136
2	Statins	Sta	3040
3	Furosemide	Fur	554
4	NAC	NAC	6095
5	Trimetazidine	Tri	352
6	NaHCO3	NaH	3393
7	PGE1	PGE	304
8	MgSO4	MgS	62
9	Pentoxifylline	Pen	438
10	Placebo	Pla	7044
11	Control	Con	9120
12	Allopurinol	All	204
13	BNP	BNP	744
14	Probucol	Pro	198
15	α-tocopherol	α-t	312
16	γ-tocopherol	γ-t	102
17	Oxygen	Oxy	346
18	Amlodipine and Valsartan	Aml	45
19	K/Na citrate	K/N	203
20	Nicorandil	Nic	291
21	Ascorbic Acid	Asc	552
22	Alpha-Lipoic Acid	Alp	139
23	Oral Hydration	Ora	254
24	Nebivolol	Neb	40
25	Anisodamine	Ani	192
26	RIPC	RIP	608
27	Theophylline	The	384
28	Hypothermia	Hyp	58
29	Glutathione	Glu	421
30	MESNA	MES	51
31	ACEI	AC	129
32	Aminophylline	Ami	45
33	Iloprost	Ilo	118
34	Acetazolamide	Ace	94
35	ANP	ANP	202
36	Zinc	Zin	18
37	Dialysis	Dia	293
38	Fenoldopam	Fe	333
39	ERAs	ER	77
40	CCB	CC	42
41	Dopamine	Do	48
42	Mannitol	Ma	35
43	Cordyceps	Co	88
44	Silymarin	Si	69

ACEI Angiotensin Converting-Enzyme Inhibitor, ANP Atrial Natriuretic Peptide, BNP B-Type Natriuretic Peptide, CCB Calcium Channels Blockers, CI-AKI Contrast Induced Acute Kidney Injury, CIN Contrast Induced Nephropathy, ERAs Endothelin Receptor Antagonism, MESNA 2-Mercaptoethane Sulfonate Sodium, MgSo4 Magnesium Sulphate, NAC N-acetyl cysteine, NaHco3 Sodium Bicarbonate, PGE1 Prostaglandin E1, RIPC Remote Ischemic Preconditioning